Clinical Trial Update: Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update from NIAID on anti-HIV drugs in Ugandan patients with HIV and tuberculosis, with the trial status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Tuberculosis | Phase 3 | Status: COMPLETED